Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7522 | 1279 | 30.2 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
85 | 25913 | MULTIPLE SCLEROSIS//MULTIPLE SCLEROSIS JOURNAL//NEUROMYELITIS OPTICA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OPTIC NEURITIS | Author keyword | 114 | 32% | 23% | 292 |
2 | RETINAL SEGMENTATION | Author keyword | 9 | 83% | 0% | 5 |
3 | LOW CONTRAST LETTER ACUITY | Author keyword | 6 | 100% | 0% | 4 |
4 | OPTIC NEURITIS TREATMENT TRIAL | Author keyword | 6 | 100% | 0% | 4 |
5 | DEMYELINATING OPTIC NEURITIS | Author keyword | 4 | 75% | 0% | 3 |
6 | PERIPHLEBITIS RETINAE | Author keyword | 4 | 75% | 0% | 3 |
7 | RETINAL NERVE FIBRE LAYER | Author keyword | 4 | 19% | 1% | 18 |
8 | EP SCORE | Author keyword | 3 | 100% | 0% | 3 |
9 | OPT NEURITIS STUDY GRP | Address | 3 | 100% | 0% | 3 |
10 | BILATERAL OPTIC NEURITIS | Author keyword | 3 | 50% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TREATMENT TRIAL | 89 | 55% | 9% | 111 |
2 | AXONAL LOSS | 41 | 30% | 9% | 114 |
3 | NEURITIS | 33 | 19% | 12% | 157 |
4 | CONTRAST LETTER ACUITY | 30 | 64% | 2% | 29 |
5 | NEURITIS TREATMENT TRIAL | 22 | 38% | 4% | 47 |
6 | DEVELOPING MULTIPLE SCLEROSIS | 20 | 66% | 1% | 19 |
7 | RETROBULBAR NEURITIS | 13 | 53% | 1% | 17 |
8 | OPTIC NEURITIS | 10 | 11% | 7% | 87 |
9 | MICROCYSTIC MACULAR EDEMA | 10 | 57% | 1% | 12 |
10 | VISUAL FIELD PROFILE | 8 | 60% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Optic neuritis | 2014 | 16 | 163 | 50% |
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography | 2015 | 2 | 71 | 52% |
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis | 2010 | 102 | 92 | 61% |
Management of acute optic neuritis | 2002 | 87 | 65 | 49% |
Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis | 2009 | 31 | 102 | 63% |
Vision in Multiple Sclerosis: The Story, Structure-Function Correlations, and Models for Neuroprotection | 2011 | 17 | 97 | 64% |
The visual pathway as a model to understand brain damage in multiple sclerosis | 2014 | 1 | 40 | 93% |
Optical coherence tomography in optic neuritis and multiple sclerosis: a review | 2007 | 42 | 30 | 57% |
Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology | 2000 | 52 | 16 | 63% |
Optical coherence tomography: a window into the mechanisms of multiple sclerosis | 2008 | 71 | 54 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OPT NEURITIS STUDY GRP | 3 | 100% | 0.2% | 3 |
2 | NEUROCURE CLIN | 3 | 11% | 1.7% | 22 |
3 | UNIV NEUROL CLIN | 2 | 67% | 0.2% | 2 |
4 | CECILIE VOGT CLIN | 1 | 38% | 0.2% | 3 |
5 | HOSP UNIV FT FRANCE | 1 | 100% | 0.2% | 2 |
6 | MJ OPHTHALMOL | 1 | 100% | 0.2% | 2 |
7 | MULTIPLE SCLEROSIS REHABIL UNIT | 1 | 50% | 0.2% | 2 |
8 | MULTIPROFILE HOSP ACT TREATMENT | 1 | 100% | 0.2% | 2 |
9 | SCI IRCCS S MARIA NASCENTE | 1 | 50% | 0.2% | 2 |
10 | CLIN EXPT MULTIPLE SCLEROSIS | 1 | 14% | 0.6% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155293 | PATTERN ELECTRORETINOGRAM//MULTIFOCAL VISUAL EVOKED POTENTIAL//CHECK SIZE |
2 | 0.0000130154 | NEUROIMAGING UNIT//NMR UNIT//MR MS |
3 | 0.0000119313 | NEUROMYELITIS OPTICA//NMO IGG//ANTI AQUAPORIN 4 ANTIBODY |
4 | 0.0000106259 | FOSTER KENNEDY SYNDROME//OPTOCILIARY SHUNT VESSELS//ANTERIOR JUNCTION SYNDROME |
5 | 0.0000101634 | CSF CEREBROSPINAL FLUID//SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 SVCAM 1//INTRAVENOUS METHYLPREDNISOLONE |
6 | 0.0000075507 | GLATIRAMER ACETATE//INTERFERON BETA//INTERFERON BETA 1B |
7 | 0.0000072633 | NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY//ANTERIOR ISCHEMIC OPTIC NEUROPATHY//ISCHEMIC OPTIC NEUROPATHY |
8 | 0.0000064759 | ACUTE DISSEMINATED ENCEPHALOMYELITIS//ADEM//BALOS CONCENTRIC SCLEROSIS |
9 | 0.0000061755 | ISOLATED MYELOPATHY//ENTANGLED HISTORIES//HLTH SCI MED RADIOL SCI |
10 | 0.0000059799 | OPTIC NERVE SHEATH MENINGIOMA//OPTIC NERVE SHEATH MENINGIOMAS//OPTIC NERVE MENINGIOMA |